91 related articles for article (PubMed ID: 2323681)
21. Increased phosphorylation of human fibrinopeptide A under acute phase conditions.
Seydewitz HH; Witt I
Thromb Res; 1985 Oct; 40(1):29-39. PubMed ID: 4089825
[TBL] [Abstract][Full Text] [Related]
22. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
Okumura N; Haneishi A; Terasawa F
Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
[TBL] [Abstract][Full Text] [Related]
23. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
24. The action of thrombin on modified fibrinogen.
Osbahr AJ
Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
[TBL] [Abstract][Full Text] [Related]
25. Proceedings: The fibrinogen-thrombin reaction.
Hogg DH; Blombäck B
Thromb Diath Haemorrh; 1975 Sep; 34(1):324. PubMed ID: 1188737
[No Abstract] [Full Text] [Related]
26. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
27. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists.
Brocal I; Marco P; Lucas J; Verdú J; Tarín F
Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428
[No Abstract] [Full Text] [Related]
28. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
29. [Static and functional biochemistry of fibrinogen. Possible practical usefulness (author's transl)].
Aznar J; Regañon E; Vila V
Sangre (Barc); 1978; 23(5B):620-30. PubMed ID: 725709
[No Abstract] [Full Text] [Related]
30. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
31. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
[TBL] [Abstract][Full Text] [Related]
32. [Endogenous thrombin potential in practical use].
Wilkens M
Hamostaseologie; 2011 May; 31(2):88-93. PubMed ID: 21152675
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation test with the calibrated automated thrombogram and anticoagulant activity of Mentha crispa.
Leite PM; Miranda APN; Amorim JM; Duarte RCF; Faraco AAG; Carvalho MDG; Castilho RO
Blood Coagul Fibrinolysis; 2020 Jan; 31(1):101-106. PubMed ID: 31644450
[TBL] [Abstract][Full Text] [Related]
34. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
35. Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
Mariani G; Iacopino G; Pasquali-Lasagni R
Int J Clin Lab Res; 1992; 22(2):111-4. PubMed ID: 1504303
[TBL] [Abstract][Full Text] [Related]
36. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
37. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
Harenberg J; Haas R; Zimmermann R
Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
Tan NH
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
[TBL] [Abstract][Full Text] [Related]
39. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
Galanakis DK; Ghebrehiwet B
J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
[TBL] [Abstract][Full Text] [Related]
40. Thrombin induces broad spectrum proteolysis in human serum samples.
O'Mullan P; Craft D; Yi J; Gelfand CA
Clin Chem Lab Med; 2009; 47(6):685-93. PubMed ID: 19099528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
